American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment patterns and predictors of survival after first line therapy in large B-cell lymphoma in a real-world US cohort
    Meeting Abstract

    McGuirk, J. P.; Fesen, M.; Ramsey, S. D.; Abou-Jawde, R.; Proli, A.; Hsu, H. L.; Patel, A. R.; Perales, M. A.; Adamson, B.; Fu, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Evaluation of risk factors for histological transformation in patients with marginal zone lymphoma (MZL): Results from a multicenter cohort study
    Meeting Abstract

    Epperla, N.; Grover, N.; Torka, P.; Karmali, R.; Annunzio, K.; Watkins, M. P.; Anampa-Guzmán, A. C.; Reves, H.; Tavakkoli, M.; Christian, B.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Peri-procedural anticoagulation interruption in acute cancer associated thrombosis
    Meeting Abstract

    Gupta, A.; Feng, K.; Derkach, A.; Leader, A.; Patell, R.
    Blood (2024)

    Fulltext@MSK | Save
  • Retrieval augmented generation for the detection of major bleeding events in the electronic health record
    Meeting Abstract

    Kaplinsky, P.; Singh, R.; Fusillo, T. F.; Leader, A.; Zwicker, J. I.; Mantha, S.
    Blood (2024)

    Fulltext@MSK | Save
  • T- and B-cell subset reconstitution as predictor of relapse in pediatric and young adult allo-hematopoietic cell transplantation patients
    Meeting Abstract

    McAvoy, D.; Thomsen, M.; Ntrivalas, E.; Klein, E.; Hosszu, K. K.; Boelens, J. J.; Oved, J. H.
    Blood (2024)

    Fulltext@MSK | Save
  • Selective inhibition of the m6a RNA reader, YTHDC1, as a novel therapeutic strategy for MYC-driven acute myeloid leukemia
    Meeting Abstract

    Arora, M.; Centore, R.; Charles, M.; Chen, Y.; Watson, M.; Czekalska, M.; Rebmann, M.; Ghandi, M.; Cattin, J.; Bharatham, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world outcomes of frontline polatuzumab and impact of frailty in older adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Iyengar, V.; Chicola, J.; Joseph, A.; Okwali, M.; Truong, R.; Bapodra, N.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Patterns of immune reconstitution and their clinical significance in aggressive lymphoma treated with CAR-T therapy
    Meeting Abstract

    Luan, D. Y.; Dewolf, S.; Fei, T.; Raj, S. S.; Shah, G. L.; Lareau, C.; Alhomoud, M.; Salles, G.; Rivas-Delgado, A.; Rejeski, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NKTR-255 vs placebo to enhance complete responses and durability following CD19-directed CAR-T therapy in patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)
    Meeting Abstract

    Ahmed, S.; Dipersio, J. F.; Essell, J. H.; Diefenbach, C. S.; Perales, M. A.; Castilla-Llorente, C.; Dahiya, S.; Chaudhry, S.; Xu, H.; Liu, Y.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Effector differentiation and exhaustion attenuate on-target, off-tumor toxicity of CD24 CAR T cells
    Meeting Abstract

    Boardman, A. P.; Rajagopalan, A.; Chen, S.; Ng, B.; Fischman, J.; Massa, A.; Elias, H. K.; Manuele, D.; Atmane, M. I.; Miranda, I.; more...
    Blood (2024)

    Fulltext@MSK | Save